首页 > 最新文献

Journal of Infection and Public Health最新文献

英文 中文
Changing landscape of pediatric influenza in Northern Mexico: A comparative clinical and virological study 墨西哥北部儿童流感的变化:一项比较临床和病毒学研究
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-17 DOI: 10.1016/j.jiph.2025.103115
Luis Carlos Hinojos-Gallardo , Andrea Jaqueline Gamboa Rodriguez , Alejandra Fierro-Torres , Eduardo Chaparro-Barrera , Enrique Guevara-Macías , Mario Soto-Ramos , César Pacheco-Tena , Susana Aideé González-Chávez

Background

Influenza remains a significant health burden in children, yet its clinical behavior and viral dynamics have shifted in recent years. These changes are particularly relevant in regions where multiple respiratory viruses co-circulate and surveillance resources are limited.

Objective

To examine how the clinical and virological profile of pediatric influenza has evolved in northern Mexico, by comparing two well-defined seasonal periods, and to contextualize these findings within national surveillance trends.

Methods

An observational, cross-sectional study was conducted in a pediatric referral hospital, including children hospitalized with acute respiratory infections during two influenza seasons (2018–2019 and 2023–2024). Clinical characteristics, laboratory findings, and RT-qPCR results were analyzed, and national surveillance reports were reviewed to identify parallel trends.

Results

A total of 274 patients were included (137 per period). Compared to the 2018–2019 cohort, the 2023–2024 cohort demonstrated a significant reduction in influenza positivity (16.8 % vs. 5.1 %, p < 0.001) and no influenza-related deaths; however, hospitalizations were more prolonged, and inflammatory markers were higher. At the national level, ILI/SARI reports increased (from 62,729 to 180,532), and confirmed influenza cases rose (from 7632 to 13,679), while positivity (from 12.2 % to 7.6 %) and mortality (from 828 to 456) declined.

Conclusions

In this pediatric hospital cohort, post-pandemic seasons showed fewer influenza cases and deaths but greater clinical severity, suggesting altered host responses after reduced viral exposure. National trends indicated broader detection of respiratory cases alongside lower influenza positivity, consistent with strengthened surveillance and evolving viral circulation in Mexico.
流感仍然是儿童的一个重要健康负担,但其临床行为和病毒动力学近年来发生了变化。这些变化在多种呼吸道病毒共同传播和监测资源有限的地区尤为重要。目的通过比较两个明确的季节,研究墨西哥北部儿童流感的临床和病毒学特征是如何演变的,并将这些发现与国家监测趋势联系起来。方法在某儿科转诊医院进行一项观察性横断面研究,研究对象包括2018-2019年和2023-2024年两个流感季节因急性呼吸道感染住院的儿童。分析了临床特征、实验室结果和RT-qPCR结果,并审查了国家监测报告,以确定相似的趋势。结果共纳入274例患者(每期137例)。与2018-2019年队列相比,2023-2024年队列显示流感阳性显著降低(16.8 % vs. 5.1 %,p <; 0.001),无流感相关死亡;然而,住院时间更长,炎症指标更高。在国家一级,流感病毒感染/急性呼吸道感染报告增加(从62729例增加到180532例),确诊流感病例增加(从7632例增加到13679例),而阳性(从12.2 %增加到7.6 %)和死亡率(从828例减少到456例)下降。结论:在这个儿科医院队列中,流感大流行后季节流感病例和死亡人数减少,但临床严重程度更高,表明病毒暴露减少后宿主反应发生了改变。全国趋势表明,呼吸道病例的发现范围更广,流感阳性率也较低,这与墨西哥加强监测和病毒传播的演变相一致。
{"title":"Changing landscape of pediatric influenza in Northern Mexico: A comparative clinical and virological study","authors":"Luis Carlos Hinojos-Gallardo ,&nbsp;Andrea Jaqueline Gamboa Rodriguez ,&nbsp;Alejandra Fierro-Torres ,&nbsp;Eduardo Chaparro-Barrera ,&nbsp;Enrique Guevara-Macías ,&nbsp;Mario Soto-Ramos ,&nbsp;César Pacheco-Tena ,&nbsp;Susana Aideé González-Chávez","doi":"10.1016/j.jiph.2025.103115","DOIUrl":"10.1016/j.jiph.2025.103115","url":null,"abstract":"<div><h3>Background</h3><div>Influenza remains a significant health burden in children, yet its clinical behavior and viral dynamics have shifted in recent years. These changes are particularly relevant in regions where multiple respiratory viruses co-circulate and surveillance resources are limited.</div></div><div><h3>Objective</h3><div>To examine how the clinical and virological profile of pediatric influenza has evolved in northern Mexico, by comparing two well-defined seasonal periods, and to contextualize these findings within national surveillance trends.</div></div><div><h3>Methods</h3><div>An observational, cross-sectional study was conducted in a pediatric referral hospital, including children hospitalized with acute respiratory infections during two influenza seasons (2018–2019 and 2023–2024). Clinical characteristics, laboratory findings, and RT-qPCR results were analyzed, and national surveillance reports were reviewed to identify parallel trends.</div></div><div><h3>Results</h3><div>A total of 274 patients were included (137 per period). Compared to the 2018–2019 cohort, the 2023–2024 cohort demonstrated a significant reduction in influenza positivity (16.8 % vs. 5.1 %, p &lt; 0.001) and no influenza-related deaths; however, hospitalizations were more prolonged, and inflammatory markers were higher. At the national level, ILI/SARI reports increased (from 62,729 to 180,532), and confirmed influenza cases rose (from 7632 to 13,679), while positivity (from 12.2 % to 7.6 %) and mortality (from 828 to 456) declined.</div></div><div><h3>Conclusions</h3><div>In this pediatric hospital cohort, post-pandemic seasons showed fewer influenza cases and deaths but greater clinical severity, suggesting altered host responses after reduced viral exposure. National trends indicated broader detection of respiratory cases alongside lower influenza positivity, consistent with strengthened surveillance and evolving viral circulation in Mexico.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103115"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145838648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suboptimal primaquine adherence in Plasmodium vivax malaria: Evidence from high-burden tribal districts in Odisha 间日疟原虫疟疾的次优伯氨喹依从性:来自奥里萨邦高负担部落地区的证据
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-30 DOI: 10.1016/j.jiph.2025.103123
Anju Viswan K , Kannan Thiruvengadam , Rohit Sharma, Nandhini Perumalsamy, Renuka Devi Arumugam, Srikanth Srirama, Arya Rahul , Manju Rahi

Background

Eliminating Plasmodium vivax malaria in India’s tribal regions is challenging, mainly due to poor adherence to primaquine, the only hypnozoiticidal drug for radical cure under national policy. Incomplete adherence to the 14-day primaquine regimen leads to relapse, treatment failure, ongoing transmission, and may contribute to antimalarial resistance. This study quantified primaquine adherence, and explored behavioral factors influencing non-adherence in high-burden tribal districts of Odisha.

Methods

This prospective cohort study conducted from January to December 2024 in two high-burden tribal districts (Malkangiri, Koraput) enrolled 269 laboratory-confirmed P. vivax patients aged over one year. Structured questionnaires collected demographic, clinical, and treatment data. Adherence to the 14-day primaquine regimen was assessed on days 7 and 14 via self-report, pill counts, and blister pack inspection. Uni- and multivariable analyses identified predictors of non-adherence.

Results

Adherence to chloroquine (3 days) and artesunate–SP (mixed infections) exceeded 93 %, while only 58.7 % (95 % CI: 52.6–64.9) completed the 14-day primaquine course. Healthcare workers dispensed drugs according to guidelines. Treatment discontinuation was mainly due to symptom resolution (61.9 %) and forgetfulness (21.4 %); only one patient discontinued primaquine due to an adverse event. Older age and household malaria history were associated with better adherence.

Conclusion

Suboptimal primaquine adherence delays P. vivax elimination despite adequate drug supply and correct dosing. Addressing behavioral drivers of early treatment cessation is critical to interrupt relapse transmission. Programmatic focus should include intensified social behavior change communication, targeted directly observed therapy, and evaluation of shorter primaquine or single-dose tafenoquine treatments with G6PD testing to enhance radical cure and accelerate India’s 2030 malaria elimination goal.
背景:在印度部落地区划定间日疟原虫疟疾是一项挑战,主要是由于对伯氨喹的依从性差,而伯氨喹是国家政策下唯一用于根治的催眠杀虫药物。不完全坚持14天伯氨喹治疗方案会导致复发、治疗失败、持续传播,并可能导致抗疟药耐药性。本研究量化了奥里萨邦高负担部落地区的伯氨喹依从性,并探讨了影响不依从性的行为因素。方法本前瞻性队列研究于2024年1月至12月在两个高负担部落区(Malkangiri, Koraput)进行,纳入269例1岁以上实验室确诊的间日疟原虫患者。结构化问卷收集了人口统计、临床和治疗数据。在第7天和第14天通过自我报告、药片计数和泡罩包装检查来评估14天伯氨喹方案的依从性。单变量和多变量分析确定了不依从性的预测因素。结果氯喹(3 d)和青蒿琥酯- sp(混合感染)的依从率超过93 %,而完成伯氨喹14 d疗程的只有58.7 %(95 % CI: 52.6 ~ 64.9)。医护人员根据指南配药。停止治疗的主要原因是症状缓解(61.9 %)和健忘(21.4% %);只有一名患者因不良事件停用伯氨喹。年龄较大和家庭疟疾史与较好的依从性相关。结论尽管有充足的药物供应和正确的剂量,但非最佳的伯氨喹依从性会延迟间日疟的消除。解决早期停止治疗的行为驱动因素对于阻断复发传播至关重要。规划重点应包括加强社会行为改变沟通,有针对性的直接观察治疗,以及评估较短的伯氨喹或单剂量他非诺喹治疗与G6PD测试,以加强根治和加速印度2030年消除疟疾的目标。
{"title":"Suboptimal primaquine adherence in Plasmodium vivax malaria: Evidence from high-burden tribal districts in Odisha","authors":"Anju Viswan K ,&nbsp;Kannan Thiruvengadam ,&nbsp;Rohit Sharma,&nbsp;Nandhini Perumalsamy,&nbsp;Renuka Devi Arumugam,&nbsp;Srikanth Srirama,&nbsp;Arya Rahul ,&nbsp;Manju Rahi","doi":"10.1016/j.jiph.2025.103123","DOIUrl":"10.1016/j.jiph.2025.103123","url":null,"abstract":"<div><h3>Background</h3><div>Eliminating <em>Plasmodium vivax</em> malaria in India’s tribal regions is challenging, mainly due to poor adherence to primaquine, the only hypnozoiticidal drug for radical cure under national policy. Incomplete adherence to the 14-day primaquine regimen leads to relapse, treatment failure, ongoing transmission, and may contribute to antimalarial resistance. This study quantified primaquine adherence, and explored behavioral factors influencing non-adherence in high-burden tribal districts of Odisha.</div></div><div><h3>Methods</h3><div>This prospective cohort study conducted from January to December 2024 in two high-burden tribal districts (Malkangiri, Koraput) enrolled 269 laboratory-confirmed <em>P. vivax</em> patients aged over one year. Structured questionnaires collected demographic, clinical, and treatment data. Adherence to the 14-day primaquine regimen was assessed on days 7 and 14 via self-report, pill counts, and blister pack inspection. Uni- and multivariable analyses identified predictors of non-adherence.</div></div><div><h3>Results</h3><div>Adherence to chloroquine (3 days) and artesunate–SP (mixed infections) exceeded 93 %, while only 58.7 % (95 % CI: 52.6–64.9) completed the 14-day primaquine course. Healthcare workers dispensed drugs according to guidelines. Treatment discontinuation was mainly due to symptom resolution (61.9 %) and forgetfulness (21.4 %); only one patient discontinued primaquine due to an adverse event. Older age and household malaria history were associated with better adherence.</div></div><div><h3>Conclusion</h3><div>Suboptimal primaquine adherence delays <em>P. vivax</em> elimination despite adequate drug supply and correct dosing. Addressing behavioral drivers of early treatment cessation is critical to interrupt relapse transmission. Programmatic focus should include intensified social behavior change communication, targeted directly observed therapy, and evaluation of shorter primaquine or single-dose tafenoquine treatments with G6PD testing to enhance radical cure and accelerate India’s 2030 malaria elimination goal.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103123"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance 在HIV感染者中超越COVID-19:特异性miRNA表达谱在SARS-CoV-2清除后持续存在
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-13 DOI: 10.1016/j.jiph.2025.103108
Sergio Grande-García , Manuel Llamas-Adán , Celia Crespo-Bermejo , Violeta Lara-Aguilar , Sonia Arca-Lafuente , Luz Martín-Carbonero , Pablo Ryan , Ignacio de los Santos , María de Lagarde , Rafael Mican-Rivera , Santiago Moreno , Salvador Resino , Juan Berenguer , Verónica Briz , Amanda Fernández-Rodríguez , on behalf of the Multidisciplinary HIV/Hepatitis Viral Coinfection Group (COVIHEP) and of the CoRIS cohort

Background

The impact of SARS-CoV-2 on epigenetic regulation in people with HIV (PWHIV) is not well understood. MicroRNAs, key post-transcriptional regulators, may serve as biomarkers of disease. This study aimed to identify plasma miRNAs reflecting epigenetic changes in PWHIV after SARS-CoV-2 resolution.

Methods

We sequenced plasma smallRNA from 20 PWHIV at a median of 10 weeks after SARS-CoV-2 infection, and 18 SARS-CoV-2 uninfected and unvaccinated PWHIV. MirDeep2 was used for miRNA identification, and significant differential expression (SDE) and classification performance were calculated using GLMs and PLS-DA. Correlations were performed using spearman test. Target enrichment was analyzed using miRTarbase, RNAInter, and KEGG databases, and tissue expression was analysed using the IMOTA database.

Results

Thirty-five microRNAs were SDE between groups. Hsa-mir-181a-2–3p was correlated to time elapsed since SARS-CoV-2 infection and sampling. Functional enrichment analysis predicted 410 target genes, which in turn overrepresented 52 cellular pathways, mainly related to neurodegeneration, major signaling cascades, and oncologic and cardiovascular diseases. The most significant pathways were Huntington's disease and PI3K-Akt signalling pathway, while those with the highest number of targeted genes were Pathways of neurodegeneration and Alzheimer's disease. The hsa-miR-374b-5p showed excellent predictive ability in classifying the SARS-CoV-2 infection status in more than 93 % of all instances.

Conclusion

SARS-CoV-2 infection in PWHIV leaves an epigenetic signature of 35 SDE microRNAs, with hsa-miR-374b-5p as a strong post-infection marker. These microRNAs regulate genes mainly involved in neurodegenerative, cardiovascular, and oncologic processes, potentially underlying post-COVID symptomatology.
SARS-CoV-2对HIV感染者(PWHIV)表观遗传调控的影响尚不清楚。microrna是关键的转录后调控因子,可作为疾病的生物标志物。本研究旨在鉴定反映SARS-CoV-2溶解后PWHIV表观遗传变化的血浆mirna。方法对20例感染SARS-CoV-2后中位时间为10周的PWHIV和18例未感染SARS-CoV-2且未接种疫苗的PWHIV的血浆小rna进行测序。MirDeep2用于miRNA鉴定,GLMs和PLS-DA计算显著差异表达(SDE)和分类性能。相关性采用spearman检验。使用miRTarbase、RNAInter和KEGG数据库分析目标富集,使用IMOTA数据库分析组织表达。结果组间有35个microrna发生SDE。Hsa-mir-181a-2-3p与SARS-CoV-2感染和采样后的时间相关。功能富集分析预测了410个靶基因,这反过来又代表了52个细胞通路,主要与神经变性、主要信号级联、肿瘤和心血管疾病有关。最显著的通路是亨廷顿病和PI3K-Akt信号通路,而靶向基因数量最多的是神经变性和阿尔茨海默病通路。hsa-miR-374b-5p在超过93% %的病例中对SARS-CoV-2感染状态进行分类显示出出色的预测能力。结论sars - cov -2感染在PWHIV中留下了35个SDE microrna的表观遗传特征,其中hsa-miR-374b-5p是一个很强的感染后标记。这些微小rna调节主要参与神经退行性、心血管和肿瘤过程的基因,可能是covid后症状的基础。
{"title":"Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance","authors":"Sergio Grande-García ,&nbsp;Manuel Llamas-Adán ,&nbsp;Celia Crespo-Bermejo ,&nbsp;Violeta Lara-Aguilar ,&nbsp;Sonia Arca-Lafuente ,&nbsp;Luz Martín-Carbonero ,&nbsp;Pablo Ryan ,&nbsp;Ignacio de los Santos ,&nbsp;María de Lagarde ,&nbsp;Rafael Mican-Rivera ,&nbsp;Santiago Moreno ,&nbsp;Salvador Resino ,&nbsp;Juan Berenguer ,&nbsp;Verónica Briz ,&nbsp;Amanda Fernández-Rodríguez ,&nbsp;on behalf of the Multidisciplinary HIV/Hepatitis Viral Coinfection Group (COVIHEP) and of the CoRIS cohort","doi":"10.1016/j.jiph.2025.103108","DOIUrl":"10.1016/j.jiph.2025.103108","url":null,"abstract":"<div><h3>Background</h3><div>The impact of SARS-CoV-2 on epigenetic regulation in people with HIV (PWHIV) is not well understood. MicroRNAs, key post-transcriptional regulators, may serve as biomarkers of disease. This study aimed to identify plasma miRNAs reflecting epigenetic changes in PWHIV after SARS-CoV-2 resolution.</div></div><div><h3>Methods</h3><div>We sequenced plasma smallRNA from 20 PWHIV at a median of 10 weeks after SARS-CoV-2 infection, and 18 SARS-CoV-2 uninfected and unvaccinated PWHIV. MirDeep2 was used for miRNA identification, and significant differential expression (SDE) and classification performance were calculated using GLMs and PLS-DA. Correlations were performed using spearman test. Target enrichment was analyzed using miRTarbase, RNAInter, and KEGG databases, and tissue expression was analysed using the IMOTA database.</div></div><div><h3>Results</h3><div>Thirty-five microRNAs were SDE between groups. Hsa-mir-181a-2–3p was correlated to time elapsed since SARS-CoV-2 infection and sampling. Functional enrichment analysis predicted 410 target genes, which in turn overrepresented 52 cellular pathways, mainly related to neurodegeneration, major signaling cascades, and oncologic and cardiovascular diseases. The most significant pathways were Huntington's disease and PI3K-Akt signalling pathway, while those with the highest number of targeted genes were Pathways of neurodegeneration and Alzheimer's disease. The hsa-miR-374b-5p showed excellent predictive ability in classifying the SARS-CoV-2 infection status in more than 93 % of all instances.</div></div><div><h3>Conclusion</h3><div>SARS-CoV-2 infection in PWHIV leaves an epigenetic signature of 35 SDE microRNAs, with hsa-miR-374b-5p as a strong post-infection marker. These microRNAs regulate genes mainly involved in neurodegenerative, cardiovascular, and oncologic processes, potentially underlying post-COVID symptomatology.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103108"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics of six fatal cases with advanced HIV and monkeypox virus co-infection in Beijing: A retrospective analysis 北京地区6例晚期HIV伴猴痘病毒合并感染致死性病例临床特点回顾性分析
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-01-02 DOI: 10.1016/j.jiph.2025.103126
Lulu Xing , Jialu Li , Yifan Guo , Ying Liu , Jiang Xiao , Hongxin Zhao

Background

Recent findings on the outbreak of mpox indicate that immunosuppressed people are at significantly higher risk of death. The aims of the research were to provide a summary of the clinical features of mpox fatal cases, explore the effects of immunosuppression, monkeypox virus (MPXV)/human immunodeficiency virus (HIV) co-infection, and delayed antiretroviral therapy (ART) on prognosis, and offer evidence-based recommendations to inform clinical practices.

Methods

Demographic information, detailed HIV disease characteristics, ART history, mpox clinical features, laboratory results, and radiological evaluations were retrospectively extracted from electronic medical records.

Results

Six fatal cases were men who have sex with men (MSM), with a median age of 35 years (range: 23–37 years). Their median CD4+ count was 51 cells/μL (range: 2–116 cells/μL). Of these cases, two were simultaneously diagnosed with MPXV/HIV infection, one was diagnosed with HIV infection and never initiated ART, and the other three had interrupted ART prior to mpox diagnosis. All patients started or restarted ART, with a medium time from initiation of ART to death being 52 days (range: 20–148 days). Besides such symptoms like skin lesions and lymphadenopathy, all of them developed severe complications, including bacterial co-infections (n = 5), pneumonia (n = 5), intestinal obstruction (n = 2), and ocular involvement (n = 3). The median intervals between symptom onset and hospitalization or death were 30 days (range: 6–36 days) and 59 days (range: 32–110 days), respectively, with all death being due to sepsis or related multiple organ failure.

Conclusion

The combination of MPXV with advanced HIV infection carries an excessive risk of death, generated by severe immunodeficiency that facilitates serious secondary infections and MPXV dissemination. Even if ART is initiated as soon as possible, immune function cannot be restored quickly enough to clear MPXV.
背景:最近关于麻疹暴发的调查结果表明,免疫抑制者的死亡风险明显更高。本研究旨在总结m痘致死性病例的临床特点,探讨免疫抑制、猴痘病毒(MPXV)/人类免疫缺陷病毒(HIV)合并感染和延迟抗逆转录病毒治疗(ART)对预后的影响,并为临床实践提供循证建议。方法回顾性提取电子病历中的人口统计信息、详细的HIV疾病特征、ART病史、mpox临床特征、实验室结果和影像学评价。结果6例死亡病例为男男性行为者(MSM),中位年龄35岁(范围23 ~ 37岁)。CD4+计数中位数为51个细胞/μL(范围2 ~ 116个细胞/μL)。在这些病例中,2例同时被诊断为MPXV/HIV感染,1例被诊断为HIV感染但从未开始抗逆转录病毒治疗,另外3例在m痘诊断之前中断了抗逆转录病毒治疗。所有患者开始或重新开始抗逆转录病毒治疗,从开始抗逆转录病毒治疗到死亡的中间时间为52天(范围:20-148天)。除皮肤病变、淋巴结病变等症状外,所有患者均出现严重并发症,包括细菌合并感染(n = 5)、肺炎(n = 5)、肠梗阻(n = 2)、眼部受累(n = 3)。从症状出现到住院或死亡的中位间隔时间分别为30天(范围6-36天)和59天(范围32-110天),所有死亡均因败血症或相关的多器官衰竭。结论MPXV合并晚期HIV感染具有过高的死亡风险,严重免疫缺陷导致严重继发感染和MPXV传播。即使尽早开始抗逆转录病毒治疗,免疫功能也不能迅速恢复到足以清除MPXV。
{"title":"Clinical characteristics of six fatal cases with advanced HIV and monkeypox virus co-infection in Beijing: A retrospective analysis","authors":"Lulu Xing ,&nbsp;Jialu Li ,&nbsp;Yifan Guo ,&nbsp;Ying Liu ,&nbsp;Jiang Xiao ,&nbsp;Hongxin Zhao","doi":"10.1016/j.jiph.2025.103126","DOIUrl":"10.1016/j.jiph.2025.103126","url":null,"abstract":"<div><h3>Background</h3><div>Recent findings on the outbreak of mpox indicate that immunosuppressed people are at significantly higher risk of death. The aims of the research were to provide a summary of the clinical features of mpox fatal cases, explore the effects of immunosuppression, monkeypox virus (MPXV)/human immunodeficiency virus (HIV) co-infection, and delayed antiretroviral therapy (ART) on prognosis, and offer evidence-based recommendations to inform clinical practices.</div></div><div><h3>Methods</h3><div>Demographic information, detailed HIV disease characteristics, ART history, mpox clinical features, laboratory results, and radiological evaluations were retrospectively extracted from electronic medical records.</div></div><div><h3>Results</h3><div>Six fatal cases were men who have sex with men (MSM), with a median age of 35 years (range: 23–37 years). Their median CD4<sup>+</sup> count was 51 cells/μL (range: 2–116 cells/μL). Of these cases, two were simultaneously diagnosed with MPXV/HIV infection, one was diagnosed with HIV infection and never initiated ART, and the other three had interrupted ART prior to mpox diagnosis. All patients started or restarted ART, with a medium time from initiation of ART to death being 52 days (range: 20–148 days). Besides such symptoms like skin lesions and lymphadenopathy, all of them developed severe complications, including bacterial co-infections (n = 5), pneumonia (n = 5), intestinal obstruction (n = 2), and ocular involvement (n = 3). The median intervals between symptom onset and hospitalization or death were 30 days (range: 6–36 days) and 59 days (range: 32–110 days), respectively, with all death being due to sepsis or related multiple organ failure.</div></div><div><h3>Conclusion</h3><div>The combination of MPXV with advanced HIV infection carries an excessive risk of death, generated by severe immunodeficiency that facilitates serious secondary infections and MPXV dissemination. Even if ART is initiated as soon as possible, immune function cannot be restored quickly enough to clear MPXV.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103126"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145977898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological and clinical trends in pediatric dengue: A six-year retrospective hospital-based study on pre-vs pandemic patterns in Puducherry, India 儿科登革热的流行病学和临床趋势:印度普杜切里一项基于医院的6年回顾性研究
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-29 DOI: 10.1016/j.jiph.2025.103121
Arya Rahul , Gnanasekaran Vijayalaksmi , Balakrishnan Vijayakumar , R. Amala , B.V. Balachandar , Thekkumkara Surendran Anish

Background

Dengue is a rapidly spreading mosquito-borne viral disease posing a significant public health challenge across tropical and subtropical regions, including India. While children are particularly vulnerable, age-specific clinical and epidemiological trends remain underexplored, especially in low-and middle-income country settings. This study describes the clinical and epidemiological trends of pediatric dengue in Puducherry from 2017 to 2022 and the impact of the COVID-19 pandemic on the disease trends.

Methods

A retrospective review was conducted on 632 pediatric patients admitted with dengue fever to a woman and child speciality public sector tertiary care hospital in Puducherry between 2017 and 2022. Data on demographic, clinical, and laboratory parameters were extracted from inpatient records. Dengue severity was categorized using WHO 2009 criteria. Statistical analyses were performed to assess associations and identify risk factors.

Results

Among the 632 patients, 54 % showed warning signs of dengue, and 3.5 % progressed to severe dengue. Fever (99.0 %), vomiting(51.3 %), and abdominal pain(37.3 %) were the common symptoms. Children under five years were significantly more likely to present with respiratory symptoms (cough: OR 1.85(1.27–2.70), p = 0.001; rhinitis: OR 1.67(1.13–2.46), p = 0.01), while gastrointestinal and musculoskeletal complaints were more common in the older children. The mean duration from symptom onset to diagnosis was 5.8 ± 2.8 days, with a significant prolongation in children aged 1–5 years (6.5 ± 3.6 days, p = 0.013). During the COVID-19 pandemic (2020–2022), time to diagnosis increased significantly (≥7 days in 27.2 % vs. 15.5 % pre-pandemic, OR 2.03, p < 0.001), although no significant differences in disease severity or demographic characteristics were noted.

Conclusions

This study highlights distinct age-related clinical patterns in pediatric dengue, with younger children tending to present more likely with respiratory symptoms and experience a longer time to diagnosis. Strengthening clinical recognition, adapting age-appropriate diagnostic protocols, and promoting early care-seeking are essential for timely detection and response to dengue in endemic regions.
登革热是一种迅速传播的蚊媒病毒性疾病,对包括印度在内的热带和亚热带地区的公共卫生构成重大挑战。虽然儿童特别脆弱,但针对特定年龄的临床和流行病学趋势仍未得到充分探讨,特别是在低收入和中等收入国家环境中。本研究描述了2017 - 2022年普杜切里县儿童登革热的临床和流行病学趋势,以及2019冠状病毒病大流行对疾病趋势的影响。方法对2017 - 2022年印度普杜切里市某妇幼专科公立三级医院收治的632例登革热患儿进行回顾性分析。人口统计、临床和实验室参数的数据从住院患者记录中提取。根据世卫组织2009年的标准对登革热严重程度进行了分类。进行统计分析以评估关联并确定危险因素。结果632例患者中,54. %出现登革热前兆,3.5% %进展为重症登革热。常见症状为发热(99.0 %)、呕吐(51.3 %)、腹痛(37.3 %)。5岁以下儿童明显更容易出现呼吸道症状(咳嗽:OR 1.85(1.27-2.70), p = 0.001;鼻炎:OR 1.67(1.13-2.46), p = 0.01),而胃肠和肌肉骨骼疾患在年龄较大的儿童中更为常见。从症状出现到诊断的平均时间为5.8 ± 2.8天,1-5岁儿童的平均时间明显延长(6.5 ± 3.6天,p = 0.013)。在COVID-19大流行期间(2020-2022),诊断时间显着增加(27.2% % vs. 15.5% %,OR 2.03, p <; 0.001),尽管没有注意到疾病严重程度或人口统计学特征的显着差异。结论:本研究突出了儿童登革热不同的年龄相关临床模式,年龄较小的儿童更容易出现呼吸道症状,并且需要更长的时间才能确诊。加强临床认识、调整适合年龄的诊断方案和促进早期求医,对于在登革热流行地区及时发现和应对登革热至关重要。
{"title":"Epidemiological and clinical trends in pediatric dengue: A six-year retrospective hospital-based study on pre-vs pandemic patterns in Puducherry, India","authors":"Arya Rahul ,&nbsp;Gnanasekaran Vijayalaksmi ,&nbsp;Balakrishnan Vijayakumar ,&nbsp;R. Amala ,&nbsp;B.V. Balachandar ,&nbsp;Thekkumkara Surendran Anish","doi":"10.1016/j.jiph.2025.103121","DOIUrl":"10.1016/j.jiph.2025.103121","url":null,"abstract":"<div><h3>Background</h3><div>Dengue is a rapidly spreading mosquito-borne viral disease posing a significant public health challenge across tropical and subtropical regions, including India. While children are particularly vulnerable, age-specific clinical and epidemiological trends remain underexplored, especially in low-and middle-income country settings. This study describes the clinical and epidemiological trends of pediatric dengue in Puducherry from 2017 to 2022 and the impact of the COVID-19 pandemic on the disease trends.</div></div><div><h3>Methods</h3><div>A retrospective review was conducted on 632 pediatric patients admitted with dengue fever to a woman and child speciality public sector tertiary care hospital in Puducherry between 2017 and 2022. Data on demographic, clinical, and laboratory parameters were extracted from inpatient records. Dengue severity was categorized using WHO 2009 criteria. Statistical analyses were performed to assess associations and identify risk factors.</div></div><div><h3>Results</h3><div>Among the 632 patients, 54 % showed warning signs of dengue, and 3.5 % progressed to severe dengue. Fever (99.0 %), vomiting(51.3 %), and abdominal pain(37.3 %) were the common symptoms. Children under five years were significantly more likely to present with respiratory symptoms (cough: OR 1.85(1.27–2.70), p = 0.001; rhinitis: OR 1.67(1.13–2.46), p = 0.01), while gastrointestinal and musculoskeletal complaints were more common in the older children. The mean duration from symptom onset to diagnosis was 5.8 ± 2.8 days, with a significant prolongation in children aged 1–5 years (6.5 ± 3.6 days, p = 0.013). During the COVID-19 pandemic (2020–2022), time to diagnosis increased significantly (≥7 days in 27.2 % vs. 15.5 % pre-pandemic, OR 2.03, p &lt; 0.001), although no significant differences in disease severity or demographic characteristics were noted.</div></div><div><h3>Conclusions</h3><div>This study highlights distinct age-related clinical patterns in pediatric dengue, with younger children tending to present more likely with respiratory symptoms and experience a longer time to diagnosis. Strengthening clinical recognition, adapting age-appropriate diagnostic protocols, and promoting early care-seeking are essential for timely detection and response to dengue in endemic regions.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103121"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145882188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular and bacteriological characterization of colistin and carbapenem-resistant nosocomial isolates of Acinetobacter baumannii isolated from different Iraqi hospitals 伊拉克不同医院鲍曼不动杆菌耐粘菌素和耐碳青霉烯医院分离株的分子和细菌学特征
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-26 DOI: 10.1016/j.jiph.2025.103118
Dhuha A. Abbas , Mushtak T.S. Al-Ouqaili , Mohammed J. Alfeehan

Background

Colistin- and carbapenem-resistant Acinetobacter (A.) baumannii pose a global health threat in healthcare settings due to difficult-to-treat infections. This study investigates their prevalence, resistance mechanisms, and the role of biofilm formation in persistence and pathogenicity.

Patients and methods

This cross-sectional observational study was conducted on 335 clinical specimens, specifically isolates of A. baumannii, during the period from December to July 2025. Bacteriological investigation was confirmed using the automated Vitek 2 compact system, and antimicrobial susceptibility was determined using the AST 419 card, in accordance with the CLSI 2025 guidelines. Biofilm formation was assessed using the microtiter plate method. PCR detection for carbapenem and colistin-resistant genes (blaNDM, blaNDM-1, blaVIM, blaIMP, blaOXA-48) and (mcr-1, mcr-5, pmrA, and pmrB), respectively, has been done.

Results

A total of 335 clinical study specimens were analyzed, with 222 (66.2 %) representing bacterial growth. Of these, 64 (28.8 %) were well bacteriologically identified as A. baumannii. Out of these isolates, 50 were multidrug resistant, classified into 31 (62 %) as extensively drug resistant (XDR) and 19 (38 %) as Pan-drug resistant. Biofilm formation was distributed as strong biofilm formation in sputum (31.2 %), wound swabs (25 %), urine (7.1 %), and vaginal swabs (100 %). Molecular analysis revealed that blaNDM-1 (18 %) was the most common carbapenemase-resistant gene, followed by blaVIM (16 %), blaIMP-1 (12 %), blaNDM (4 %), and blaOXA-48 (2 %). For colistin resistance, pmrB (54 %) and pmrA (40 %) were predominant, while mcr-1 was (4 %). Notably, mcr-5 was not detected in all colistin-resistant genes.

Conclusion

Most A. baumannii isolates were extensively drug-resistant or pan-drug-resistant and exhibited variable biofilm formation, likely enhancing persistence in hospital environments. High prevalence of blaNDM-1 and blaVIM  carbapenem resistance genes, along with pmrB and pmrA colistin resistance genes, complicates treatment and diagnostics. Prompt detection, effective infection control, and continuous surveillance are urgently needed to limit the spread of these highly resistant strains.
由于难以治疗的感染,耐粘菌素和碳青霉烯不动杆菌(a .)鲍曼尼在医疗保健环境中构成全球健康威胁。本研究探讨了它们的流行、耐药机制以及生物膜形成在持久性和致病性中的作用。患者和方法本横断面观察研究于2025年12月至7月期间对335例临床标本,特别是鲍曼不动杆菌分离株进行了研究。根据CLSI 2025指南,使用自动Vitek 2紧凑型系统确认细菌学调查,并使用AST 419卡确定抗菌药物敏感性。采用微量滴度板法评估生物膜的形成。PCR检测碳青霉烯类耐药基因blaNDM、blaNDM-1、blaVIM、blaIMP、blaOXA-48和mcr-1、mcr-5、pmrA、pmrB。结果共分析临床研究标本335份,其中222份(66.2% %)为细菌生长。其中64例(28.8 %)经细菌学鉴定为鲍曼不动杆菌。其中50株为多药耐药,31株(62 %)为广泛耐药(XDR), 19株(38 %)为泛耐药。在痰液(31.2 %)、伤口拭子(25 %)、尿液(7.1 %)和阴道拭子(100 %)中形成强烈的生物膜。分子分析显示,blaNDM-1(18 %)是最常见的碳青霉烯酶耐药基因,其次是blaVIM(16 %)、blaIMP-1(12 %)、blaNDM(4 %)和blaOXA-48(2 %)。粘菌素耐药以pmrB(54 %)和pmrA(40 %)为主,mcr-1(4 %)为主。值得注意的是,并没有在所有的粘菌素耐药基因中检测到mcr-5。结论大多数鲍曼不动杆菌分离株具有广泛耐药或泛耐药,并表现出可变的生物膜形成,可能增强了在医院环境中的持久性。高流行率的blaNDM-1和blaVIM碳青霉烯耐药基因,以及pmrB和pmrA粘菌素耐药基因,使治疗和诊断复杂化。迫切需要及时发现、有效控制感染和持续监测,以限制这些高耐药菌株的传播。
{"title":"Molecular and bacteriological characterization of colistin and carbapenem-resistant nosocomial isolates of Acinetobacter baumannii isolated from different Iraqi hospitals","authors":"Dhuha A. Abbas ,&nbsp;Mushtak T.S. Al-Ouqaili ,&nbsp;Mohammed J. Alfeehan","doi":"10.1016/j.jiph.2025.103118","DOIUrl":"10.1016/j.jiph.2025.103118","url":null,"abstract":"<div><h3>Background</h3><div>Colistin- and carbapenem-resistant <em>Acinetobacter (A.) baumannii</em> pose a global health threat in healthcare settings due to difficult-to-treat infections. This study investigates their prevalence, resistance mechanisms, and the role of biofilm formation in persistence and pathogenicity.</div></div><div><h3>Patients and methods</h3><div>This cross-sectional observational study was conducted on 335 clinical specimens, specifically isolates of <em>A. baumannii</em>, during the period from December to July 2025. Bacteriological investigation was confirmed using the automated Vitek 2 compact system, and antimicrobial susceptibility was determined using the AST 419 card, in accordance with the CLSI 2025 guidelines. Biofilm formation was assessed using the microtiter plate method. PCR detection for carbapenem and colistin-resistant genes (<em>bla</em><sub><em>NDM</em></sub><em>, bla</em><sub><em>NDM-1</em></sub><em>, bla</em><sub><em>VIM</em></sub><em>, bla</em><sub><em>IMP</em></sub><em>, bla</em><sub><em>OXA-48</em></sub><em>)</em> and (<em>mcr-1</em>, <em>mcr-5</em>, <em>pmrA</em>, and <em>pmrB</em>), respectively, has been done.</div></div><div><h3>Results</h3><div>A total of 335 clinical study specimens were analyzed, with 222 (66.2 %) representing bacterial growth. Of these, 64 (28.8 %) were well bacteriologically identified as <em>A. baumannii</em>. Out of these isolates, 50 were multidrug resistant, classified into 31 (62 %) as extensively drug resistant (XDR) and 19 (38 %) as Pan-drug resistant. Biofilm formation was distributed as strong biofilm formation in sputum (31.2 %), wound swabs (25 %), urine (7.1 %), and vaginal swabs (100 %). Molecular analysis revealed that <em>bla</em><sub><em>NDM-1</em></sub> (18 %) was the most common carbapenemase-resistant gene, followed by <em>blaVIM</em> (16 %), <em>bla</em><sub><em>IMP-1</em></sub> (12 %), <em>bla</em><sub><em>NDM</em></sub> (4 %), and <em>bla</em><sub><em>OXA-48</em></sub> <em>(2 %)</em>. For colistin resistance, <em>pmrB (</em>54 %) and <em>pmrA</em> (40 %) were predominant, while <em>mcr-1</em> was (4 %). Notably, <em>mcr-5</em> was not detected in all colistin-resistant genes.</div></div><div><h3>Conclusion</h3><div>Most <em>A. baumannii</em> isolates were extensively drug-resistant or pan-drug-resistant and exhibited variable biofilm formation, likely enhancing persistence in hospital environments. High prevalence of <em>bla</em><sub><em>NDM-1</em></sub> and <em>bla</em><sub><em>VIM</em> </sub> carbapenem resistance genes, along with <em>pmrB</em> and <em>pmrA</em> colistin resistance genes, complicates treatment and diagnostics. Prompt detection, effective infection control, and continuous surveillance are urgently needed to limit the spread of these highly resistant strains.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103118"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145882190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modeling the emergence of divergent mutants of SARS-CoV-2, “Omicron-like events”: A time-to-event analysis 模拟SARS-CoV-2分化突变体的出现,“类欧米克隆事件”:时间到事件的分析。
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.jiph.2026.103140
Haruka Hayashi, Yuta Okada, Taishi Kayano, Katsuma Hayashi, Tetsuro Kobayashi, Hiroshi Nishiura

Background

During the COVID-19 pandemic, several divergent mutants including the Omicron (B.1.1.529) BA.1 variant emerged, having a distinct mechanism of emergence compared with pre-existing variants of concern. Apart from playing a major role in causing recurrent epidemic waves, the highly divergent mutants also contributed to changing the fate of the pandemic by exhibiting large differences in phenotypic characteristics among even closely related variants. Given that several different variants emerged during the pandemic, the present study aimed to quantitatively evaluate the risk of emergence of divergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants and understand the mechanism of such emergence.

Methods

Upon identifying the emergence of phylogenetically distinct variants in “Omicron-like events” that have been recognized to date, a time-to-event analysis was carried out to estimate the monthly hazard rate of emergence. Four statistical models were established and compared using the Akaike Information Criterion.

Results

The model using the number of hospitalized cases was determined to be the best fit. The risk of Omicron-like events is not independent of time; instead, the monthly risk of emergence is likely to increase over time due to an increasing number of infection events.

Conclusions

Ongoing virus genomic surveillance is vital, and possible prevention among immunosuppressed individuals should be considered.
背景:在2019冠状病毒病大流行期间,出现了包括Omicron (B.1.1.529) BA.1变体在内的几种不同的突变体,与先前存在的变体相比,它们具有不同的出现机制。高度分化的突变体除了在引起反复出现的流行病浪潮中发挥主要作用外,甚至在密切相关的变体之间也表现出表型特征的巨大差异,从而有助于改变大流行的命运。鉴于在大流行期间出现了几种不同的变体,本研究旨在定量评估发散性严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)突变体出现的风险,并了解其出现的机制。方法:在确定迄今为止已识别的“类欧米克隆事件”中出现的系统发育上不同的变异后,进行了事件时间分析,以估计每月出现的危险率。采用赤池信息准则建立了4个统计模型并进行了比较。结果:采用住院病例数模型拟合效果最佳。类似欧米克隆事件的风险并非与时间无关;相反,由于感染事件数量的增加,每月出现的风险可能会随着时间的推移而增加。结论:持续的病毒基因组监测至关重要,应考虑在免疫抑制个体中进行可能的预防。
{"title":"Modeling the emergence of divergent mutants of SARS-CoV-2, “Omicron-like events”: A time-to-event analysis","authors":"Haruka Hayashi,&nbsp;Yuta Okada,&nbsp;Taishi Kayano,&nbsp;Katsuma Hayashi,&nbsp;Tetsuro Kobayashi,&nbsp;Hiroshi Nishiura","doi":"10.1016/j.jiph.2026.103140","DOIUrl":"10.1016/j.jiph.2026.103140","url":null,"abstract":"<div><h3>Background</h3><div>During the COVID-19 pandemic, several divergent mutants including the Omicron (B.1.1.529) BA.1 variant emerged, having a distinct mechanism of emergence compared with pre-existing variants of concern. Apart from playing a major role in causing recurrent epidemic waves, the highly divergent mutants also contributed to changing the fate of the pandemic by exhibiting large differences in phenotypic characteristics among even closely related variants. Given that several different variants emerged during the pandemic, the present study aimed to quantitatively evaluate the risk of emergence of divergent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutants and understand the mechanism of such emergence.</div></div><div><h3>Methods</h3><div>Upon identifying the emergence of phylogenetically distinct variants in “Omicron-like events” that have been recognized to date, a time-to-event analysis was carried out to estimate the monthly hazard rate of emergence. Four statistical models were established and compared using the Akaike Information Criterion.</div></div><div><h3>Results</h3><div>The model using the number of hospitalized cases was determined to be the best fit. The risk of Omicron-like events is not independent of time; instead, the monthly risk of emergence is likely to increase over time due to an increasing number of infection events.</div></div><div><h3>Conclusions</h3><div>Ongoing virus genomic surveillance is vital, and possible prevention among immunosuppressed individuals should be considered.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 3","pages":"Article 103140"},"PeriodicalIF":4.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
USING GLOBAL SEQUENCE DATABASES TO INFORM AND ACCELERATE ASSAY DEVELOPMENT OF RAPID TESTS FOR NEISSERIA GONORRHOEAE ANTIMICROBIAL RESISTANCE 利用全球序列数据库为淋病奈瑟菌抗微生物药物耐药性快速检测提供信息并加快检测方法的开发
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2026-01-08 DOI: 10.1016/j.jiph.2025.103100
Abdulrahman Ayfan , Leah Roberts , David Whiley
{"title":"USING GLOBAL SEQUENCE DATABASES TO INFORM AND ACCELERATE ASSAY DEVELOPMENT OF RAPID TESTS FOR NEISSERIA GONORRHOEAE ANTIMICROBIAL RESISTANCE","authors":"Abdulrahman Ayfan ,&nbsp;Leah Roberts ,&nbsp;David Whiley","doi":"10.1016/j.jiph.2025.103100","DOIUrl":"10.1016/j.jiph.2025.103100","url":null,"abstract":"","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 2","pages":"Article 103100"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing definitions of SARS-CoV-2 infection in a prospective household transmission study 一项前瞻性家庭传播研究中SARS-CoV-2感染定义的比较
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-11-22 DOI: 10.1016/j.jiph.2025.103069
Jonas Frost , Bianca Klee , Sophie Diexer , Kristin Maria Meyer-Schlinkmann , Cornelia Gottschick , Jonas Rosendahl , Michael Gekle , Stefan Moritz , Simone Hettmer , Jessica I. Hoell , Irene Moor , Thomas Frese , Mascha Binder , Christine Dierks , Rafael Mikolajczyk

Background

Identifying SARS-CoV-2 infections in field studies, especially if they are asymptomatic or reinfections, is challenging. This study aims to compare definitions of an infection and establish an approach to detect reinfections serologically, relying on titre increase.

Methods

In a household transmission study in autumn/winter 2022, we collected information on symptoms and two serological samples in a timespan of six to eight weeks from 389 participants of the German digital cohort DigiHero. Blood samples were drawn using dried blood spot cards and analysed in regard to the SARS-CoV-2 S and N antibody. We calculated secondary attack rates (SARs) using three definitions of infection from previous literature, based on reported symptoms or seroconversion, and two approaches accounting for reinfection in serological testing.

Results

SARs differed substantially between definitions. High initial seroprevalence in the study population led to underestimation of the SAR by over 20 % when using seroconversion compared to approaches accounting for reinfections. Symptom-based definitions resulted in misclassification likely due to infections with other pathogens and by disregarding asymptomatic cases.

Conclusions

This methodological study shows that relying on seroconversion is not adequate in high sero-prevalence settings and symptom-based approaches disregard asymptomatic cases. Approaches accounting for substantial titre increases between two antibody measurements reliably identified infections regardless of seroconversion and symptoms in a longitudinal serological assessment. This method could be useful for other pathogens, where asymptomatic disease and reinfections are common.
在实地研究中识别SARS-CoV-2感染,特别是如果他们无症状或再次感染,是具有挑战性的。本研究的目的是比较感染的定义,并建立一种方法来检测再感染血清学,依靠滴度增加。方法在2022年秋冬季的一项家庭传播研究中,我们收集了来自德国数字队列DigiHero的389名参与者的症状信息和两份血清学样本,时间跨度为6至8周。使用干血抽血卡抽取血样,并对SARS-CoV-2 S和N抗体进行分析。我们使用先前文献中关于感染的三种定义(基于报告的症状或血清转换)和血清学检测中考虑再感染的两种方法来计算继发发病率(SARs)。结果不同定义的sar差异很大。与考虑再感染的方法相比,研究人群中较高的初始血清阳性率导致血清转换对SAR的低估超过20% %。基于症状的定义可能由于感染其他病原体和忽视无症状病例而导致错误分类。结论:该方法学研究表明,在高血清患病率的情况下,依赖血清转换是不够的,基于症状的方法忽视了无症状病例。在纵向血清学评估中,无论血清转化和症状如何,在两次抗体测量之间显著滴度增加的方法都可靠地确定了感染。这种方法可能对其他病原体有用,其中无症状疾病和再感染是常见的。
{"title":"Comparing definitions of SARS-CoV-2 infection in a prospective household transmission study","authors":"Jonas Frost ,&nbsp;Bianca Klee ,&nbsp;Sophie Diexer ,&nbsp;Kristin Maria Meyer-Schlinkmann ,&nbsp;Cornelia Gottschick ,&nbsp;Jonas Rosendahl ,&nbsp;Michael Gekle ,&nbsp;Stefan Moritz ,&nbsp;Simone Hettmer ,&nbsp;Jessica I. Hoell ,&nbsp;Irene Moor ,&nbsp;Thomas Frese ,&nbsp;Mascha Binder ,&nbsp;Christine Dierks ,&nbsp;Rafael Mikolajczyk","doi":"10.1016/j.jiph.2025.103069","DOIUrl":"10.1016/j.jiph.2025.103069","url":null,"abstract":"<div><h3>Background</h3><div>Identifying SARS-CoV-2 infections in field studies, especially if they are asymptomatic or reinfections, is challenging. This study aims to compare definitions of an infection and establish an approach to detect reinfections serologically, relying on titre increase.</div></div><div><h3>Methods</h3><div>In a household transmission study in autumn/winter 2022, we collected information on symptoms and two serological samples in a timespan of six to eight weeks from 389 participants of the German digital cohort DigiHero. Blood samples were drawn using dried blood spot cards and analysed in regard to the SARS-CoV-2 S and N antibody. We calculated secondary attack rates (SARs) using three definitions of infection from previous literature, based on reported symptoms or seroconversion, and two approaches accounting for reinfection in serological testing.</div></div><div><h3>Results</h3><div>SARs differed substantially between definitions. High initial seroprevalence in the study population led to underestimation of the SAR by over 20 % when using seroconversion compared to approaches accounting for reinfections. Symptom-based definitions resulted in misclassification likely due to infections with other pathogens and by disregarding asymptomatic cases.</div></div><div><h3>Conclusions</h3><div>This methodological study shows that relying on seroconversion is not adequate in high sero-prevalence settings and symptom-based approaches disregard asymptomatic cases. Approaches accounting for substantial titre increases between two antibody measurements reliably identified infections regardless of seroconversion and symptoms in a longitudinal serological assessment. This method could be useful for other pathogens, where asymptomatic disease and reinfections are common.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 2","pages":"Article 103069"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145616027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outbreak of foodborne illness caused by Salmonella Braenderup ST2443 in China: Epidemiological and pathogenic insights 中国由沙门氏菌ST2443引起的食源性疾病暴发:流行病学和病原学见解
IF 4 3区 医学 Q1 INFECTIOUS DISEASES Pub Date : 2026-02-01 Epub Date: 2025-11-17 DOI: 10.1016/j.jiph.2025.103053
Yezhen Fang , Xiaoyan Wang , Hua Yu , Rui Tian , Yiyi Wang , Pan Zhao , Shiwang Huang , Xiaoting Hua

Background

Salmonella outbreaks, particularly those caused by Salmonella Braenderup (S. Braenderup), represent a significant public health challenge due to their potential for widespread food contamination. While S. Braenderup outbreaks are reported globally, research on this serotype in China remains limited, leading to gaps in understanding its epidemiological patterns, pathogenic characteristics, and molecular features. This study investigates a foodborne outbreak in Hangzhou, China, in July 2023 to elucidate the transmission dynamics and molecular features of the causative strain.

Methods

A detailed epidemiological investigation was conducted, with rectal swabs, fecal samples, food, and environmental samples collected. Rapid pathogen detection, isolation, serotyping, and whole-genome sequencing (WGS) were performed to identify the infection source and characterize the outbreak strain. Epidemiological and genomic data were analyzed to determine the genetic relationships among isolates.

Results

Ten S. Braenderup strains, identified by the antigenic formula 6,7:e,h:e,n,z15, were isolated from patient feces, rectal swabs of restaurant employees, and food samples. All outbreak strains were classified as ST2443. WGS revealed two distinct phylogenetic clusters, with intragroup single nucleotide polymorphism (SNP) distances ranging from 2 to 503, indicating both recent common ancestry and substantial genomic diversity among the isolates. Notably, two food isolates (SCGL31 and SCGL35) exhibited close genomic relatedness to a patient isolate (SCGL39), supporting a direct link between foodborne transmission and clinical infection. The outbreak source was traced to contaminated food and infected restaurant employees. Virulence profiling identified key determinants, including invA, SPI-1 to SPI-5, and fimbrial genes. All strains demonstrated resistance to nalidixic acid. Although no acquired resistance genes were detected, a gyrA D87Y mutation associated with quinolone resistance was present.

Conclusion

This study provides the first detailed characterization of a foodborne outbreak in China caused by S. Braenderup ST2443. The findings highlight the value of WGS in outbreak investigation and underscore the necessity of stringent hygiene protocols and ongoing genomic surveillance to mitigate future risks.
沙门氏菌暴发,特别是由布氏沙门氏菌(S. Braenderup)引起的暴发,由于其可能造成广泛的食品污染,是一项重大的公共卫生挑战。虽然全球都报道了布氏沙门氏菌的暴发,但在中国对该血清型的研究仍然有限,导致对其流行病学模式、致病特征和分子特征的了解存在空白。本研究调查了2023年7月在中国杭州发生的食源性暴发,以阐明致病菌株的传播动力学和分子特征。方法进行详细的流行病学调查,收集直肠拭子、粪便、食物和环境样本。采用快速病原体检测、分离、血清分型和全基因组测序(WGS)确定感染源和暴发菌株特征。对流行病学和基因组学数据进行分析,以确定分离株之间的遗传关系。结果从患者粪便、餐馆工作人员直肠拭子和食品样品中分离到勃氏链球菌,抗原式分别为6、7:e、h:e、n、z15。所有爆发菌株都被归类为ST2443。WGS显示了两个不同的系统发育集群,群内单核苷酸多态性(SNP)距离在2到503之间,表明分离物之间有共同的祖先和大量的基因组多样性。值得注意的是,两种食物分离株(SCGL31和SCGL35)与一种患者分离株(SCGL39)表现出密切的基因组相关性,支持食源性传播与临床感染之间的直接联系。疫情源头可追溯至受污染的食物和受感染的餐厅员工。毒力分析确定了关键决定因素,包括invA、SPI-1至SPI-5和毛膜基因。所有菌株均表现出对萘啶酸的抗性。虽然没有检测到获得性耐药基因,但存在与喹诺酮类药物耐药相关的gyrA D87Y突变。结论本研究首次详细描述了由S. Braenderup ST2443引起的中国食源性暴发。这些发现突出了WGS在疫情调查中的价值,并强调了严格的卫生协议和持续的基因组监测以减轻未来风险的必要性。
{"title":"Outbreak of foodborne illness caused by Salmonella Braenderup ST2443 in China: Epidemiological and pathogenic insights","authors":"Yezhen Fang ,&nbsp;Xiaoyan Wang ,&nbsp;Hua Yu ,&nbsp;Rui Tian ,&nbsp;Yiyi Wang ,&nbsp;Pan Zhao ,&nbsp;Shiwang Huang ,&nbsp;Xiaoting Hua","doi":"10.1016/j.jiph.2025.103053","DOIUrl":"10.1016/j.jiph.2025.103053","url":null,"abstract":"<div><h3>Background</h3><div><em>Salmonella</em> outbreaks, particularly those caused by <em>Salmonella</em> Braenderup (<em>S.</em> Braenderup), represent a significant public health challenge due to their potential for widespread food contamination. While <em>S.</em> Braenderup outbreaks are reported globally, research on this serotype in China remains limited, leading to gaps in understanding its epidemiological patterns, pathogenic characteristics, and molecular features. This study investigates a foodborne outbreak in Hangzhou, China, in July 2023 to elucidate the transmission dynamics and molecular features of the causative strain.</div></div><div><h3>Methods</h3><div>A detailed epidemiological investigation was conducted, with rectal swabs, fecal samples, food, and environmental samples collected. Rapid pathogen detection, isolation, serotyping, and whole-genome sequencing (WGS) were performed to identify the infection source and characterize the outbreak strain. Epidemiological and genomic data were analyzed to determine the genetic relationships among isolates.</div></div><div><h3>Results</h3><div>Ten <em>S.</em> Braenderup strains, identified by the antigenic formula 6,7:e,h:e,n,z15, were isolated from patient feces, rectal swabs of restaurant employees, and food samples. All outbreak strains were classified as ST2443. WGS revealed two distinct phylogenetic clusters, with intragroup single nucleotide polymorphism (SNP) distances ranging from 2 to 503, indicating both recent common ancestry and substantial genomic diversity among the isolates. Notably, two food isolates (SCGL31 and SCGL35) exhibited close genomic relatedness to a patient isolate (SCGL39), supporting a direct link between foodborne transmission and clinical infection. The outbreak source was traced to contaminated food and infected restaurant employees. Virulence profiling identified key determinants, including <em>invA</em>, SPI-1 to SPI-5, and fimbrial genes. All strains demonstrated resistance to nalidixic acid. Although no acquired resistance genes were detected, a <em>gyrA</em> D87Y mutation associated with quinolone resistance was present.</div></div><div><h3>Conclusion</h3><div>This study provides the first detailed characterization of a foodborne outbreak in China caused by <em>S. Braenderup</em> ST2443. The findings highlight the value of WGS in outbreak investigation and underscore the necessity of stringent hygiene protocols and ongoing genomic surveillance to mitigate future risks.</div></div>","PeriodicalId":16087,"journal":{"name":"Journal of Infection and Public Health","volume":"19 2","pages":"Article 103053"},"PeriodicalIF":4.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145570764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection and Public Health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1